Tissue engineering therapies may be taking longer than we all hoped to get to patients, but tissue-engineered medical products keep making steady progress. With some products already commercially available, and many more in the pipeline, in vitro culture systems are becoming more and more sophisticated and instrumented.

Whether you’re working with an R&D or production-scale bioreactor, real-time monitoring of Critical Process Parameters (CPP) can provide you actionable data about your static or perfusion culture. You can use this data to better understand the metabolic activity of your cells, replace or buffer your media, modify fluid flow rate or agitation, improve reproducibility, and develop predictive models for making harvest/continue/ discontinue culture decisions.